Literature DB >> 33663471

Sensitivity and specificity of the Bamberg Dementia Screening Test's (BDST) full and short versions: brief screening instruments for geriatric patients that are suitable for infectious environments.

Wolfgang Trapp1,2, Susanne Röder3, Andreas Heid3, Pia Billman3, Susanne Daiber4, Göran Hajak3.   

Abstract

BACKGROUND: Currently, many patients suffering from dementia do not have a diagnosis when admitted to geriatric hospitals. This is the case despite an increased risk of complications affecting the length of stay and outcome. Unfortunately, many dementia screening tests cannot be used on geriatric inpatients, who are often bedridden. Therefore, we aimed at evaluating the diagnostic accuracy of a small battery of bedside tasks that require minimal vision and fine motor skills in patients with suspected dementia.
METHODS: In this prospective study, the Bamberg Dementia Screening Test (BDST) was administered to a consecutive series of 1295 patients referred for neuropsychological testing. The diagnosis of dementia was confirmed in 1159 and excluded in 136 patients. Sensitivity and specificity for the first subtest (ultra-short form), the first two subtests (short form), and the total score of the BDST were obtained via receiver operating characteristic curves and compared with the sensitivity and specificity values of the Mini-Mental Status Examination (MMSE).
RESULTS: The overall diagnostic quality of the BDST was superior to the MMSE for mild Alzheimer's dementia (sensitivity and specificity = .94 (95% CI .92 to .96) and .82 (95% CI .75 to .88) vs. .79 (95% CI .76 to .83) and .88 (95% CI .82 to .93)) as well as for other subtypes of mild dementia (sensitivity and specificity = .91 (95% CI .88 to .94) and .82 (95% CI .75 to .88) vs. .72 (95% CI .67 to .76) and .88 (95% CI .82 to .93)). Even the short form of the BDST was comparable to the MMSE regarding sensitivity and specificity. For moderate dementia, it was possible to identify dementia cases with sufficient and excellent diagnostic quality by using the ultra-short and the short form.
CONCLUSIONS: The BDST is able to detect dementia in geriatric hospital settings. If the adaptive algorithm is used, administration time can be reduced to less than 2 min in most cases. Because no test materials have to be exchanged, this test is particularly suitable for infectious environments where contact between the examiner and the person being tested should be minimized.

Entities:  

Keywords:  Alzheimer’s disease; Dementia; Diagnostic; Geriatrics; Memory; Screening test; Sensitivity; Specificity

Mesh:

Year:  2021        PMID: 33663471      PMCID: PMC7934397          DOI: 10.1186/s12916-021-01927-4

Source DB:  PubMed          Journal:  BMC Med        ISSN: 1741-7015            Impact factor:   8.775


  39 in total

1.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.

Authors:  M F Folstein; S E Folstein; P R McHugh
Journal:  J Psychiatr Res       Date:  1975-11       Impact factor: 4.791

Review 2.  Public health guidance to facilitate timely diagnosis of dementia: ALzheimer's COoperative Valuation in Europe recommendations.

Authors:  Dawn Brooker; Jenny La Fontaine; Simon Evans; Jennifer Bray; Karim Saad
Journal:  Int J Geriatr Psychiatry       Date:  2014-01-24       Impact factor: 3.485

3.  The Prevalence of Dementia and Cognitive Impairment in Hospitals.

Authors:  Horst Bickel; Ingrid Hendlmeier; Johannes Baltasar Heßler; Magdalena Nora Junge; Sarah Leonhardt-Achilles; Joshua Weber; Martina Schäufele
Journal:  Dtsch Arztebl Int       Date:  2018-11-02       Impact factor: 5.594

4.  Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis.

Authors:  Christopher G Goetz; Murat Emre; Bruno Dubois
Journal:  Ann Neurol       Date:  2008-12       Impact factor: 10.422

5.  Validity of dementia and Alzheimer's disease diagnoses in Finnish national registers.

Authors:  Alina Solomon; Tiia Ngandu; Hilkka Soininen; M Merja Hallikainen; Miia Kivipelto; Tiina Laatikainen
Journal:  Alzheimers Dement       Date:  2013-07-10       Impact factor: 21.566

6.  Validation of the Addenbrooke's Cognitive Examination III in frontotemporal dementia and Alzheimer's disease.

Authors:  Sharpley Hsieh; Samantha Schubert; Christopher Hoon; Eneida Mioshi; John R Hodges
Journal:  Dement Geriatr Cogn Disord       Date:  2013-08-15       Impact factor: 2.959

7.  Potentially preventable complications of urinary tract infections, pressure areas, pneumonia, and delirium in hospitalised dementia patients: retrospective cohort study.

Authors:  Kasia Bail; Helen Berry; Laurie Grealish; Brian Draper; Rosemary Karmel; Diane Gibson; Ann Peut
Journal:  BMJ Open       Date:  2013-06-20       Impact factor: 2.692

Review 8.  Is Dementia Screening of Apparently Healthy Individuals Justified?

Authors:  Larry W Chambers; Saskia Sivananthan; Carol Brayne
Journal:  Adv Prev Med       Date:  2017-08-08

9.  Identifying dementia cases with routinely collected health data: A systematic review.

Authors:  Tim Wilkinson; Amanda Ly; Christian Schnier; Kristiina Rannikmäe; Kathryn Bush; Carol Brayne; Terence J Quinn; Cathie L M Sudlow
Journal:  Alzheimers Dement       Date:  2018-04-03       Impact factor: 21.566

10.  Self administered cognitive screening test (TYM) for detection of Alzheimer's disease: cross sectional study.

Authors:  Jeremy Brown; George Pengas; Kate Dawson; Lucy A Brown; Philip Clatworthy
Journal:  BMJ       Date:  2009-06-09
View more
  1 in total

1.  |tPRiors |: a tool for prior elicitation and obtaining posterior distributions of true disease prevalence.

Authors:  Konstantinos Pateras; Polychronis Kostoulas
Journal:  BMC Med Res Methodol       Date:  2022-04-03       Impact factor: 4.615

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.